INTEGRATED BIOPHARMA INC (INBP) Total liabilities 2016–2025
INTEGRATED BIOPHARMA INC (INBP) total liabilities at each fiscal year-end, per SEC filings.
$4.6MFY2025 · since FY2016: $22.3M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.6M | -34.2% |
| FY2024 | $7.0M | +6.1% |
| FY2023 | $6.6M | -1.6% |
| FY2022 | $6.7M | -39.9% |
| FY2021 | $11.1M | -34.2% |
| FY2020 | $16.9M | -5.7% |
| FY2019 | $17.9M | -9.6% |
| FY2018 | $19.8M | -6.3% |
| FY2017 | $21.1M | -5.2% |
| FY2016 | $22.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice